Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

Chicago ,  US 6 - 9 November 2026

American Heart Association (AHA 2026)

Teaser video
Presentation schedule and materials
Saturday, 07 November 2026
08:35  - 08:45
CST
N230B
POSTER
Primary Report of the Ziltivekimab Cardiovascular Outcomes Trial (ZEUS)
Paul M Ridker1; A Michael Lincoff2; Nikolaus Marx3; Ann Marie Navar4; Naveed Sattar5; Katherine R Tuttle6; Lance Sloan7; Lale Tokgözoğlu8; Andreas Andersen9; Florian M M Baeres9; Kathrine Ekström9; Mads M D Engelmann9; Sofia Gerward9; G. Kees Hovingh9*; Anders Hvelplund9; and Vlado Perkovic10 on behalf of the ZEUS investigators*Affiliated with Novo Nordisk A/S at the time of the trial conduct
MATERIALS AVAILABLE
ridker-zeus-aha-draft-final
Slide
11:15  - 12:00
CST
Symposium
A change of heart: Rethinking cardiovascular care with GLP-1RAs
Stephen J. Greene ;  Leigh Perreault ;  Orly Vardeny
MATERIALS AVAILABLE
aha-sema-2026-summary-infographic-v3_0
Infographic
rethinking-cardiovascular-care-with-glp-1ras-video
Teaser Video
15:15  - 16:00
CST
Symposium
The heart of CV inflammation: Evidence and evolving science
Subodh Verma ;  Paul M Ridker ;  Ann Marie Navar
MATERIALS AVAILABLE
aha-inflammation-summary-infographic-v2_0
Infographic
the-heart-of-cv-inflammation-video
Teaser Video
Sunday, 08 November 2026
09:57  - 10:02
CST
MDP1298
POSTER
Ziltivekimab in acute myocardial infarction: rationale, design and baseline clinical characteristics of the ARTEMIS study
    
Jennifer Rymer1*; Roxana Mehran2*; Kevin R Bainey3; Deepak L Bhatt2; Davide Capodanno4; Anders Hvelplund5; Henrik Jarlov5; Maria D Radu Juul Jensen5; J Wouter Jukema6; Vijay Kunadian7; Adam J Nelson8; Duk-Woo Park9; Paul M Ridker10; Clara Saldarriaga11; Binita Shah12; P Gabriel Steg13; Adrian F Hernandez1Co-lead authors*
MATERIALS AVAILABLE
rymer-et-al-artemis-aha-poster-slides-29-oct-26-final
Slide
15:15  - 15:22
CST
Su3001
POSTER
Long-term trends in C-reactive protein and interleukin-6 levels in the Danish population: a population-based study of cardiovascular inflammation

 
Susanne Hansen1; Marius Mølsted Flege1; Lise Lotte N Husemoen2; Iram Faqir Muhammad2; Julie Thietje Mortensen2; Martin Bødtker Mortensen3; Shahzleen Rajan2; Ulrich Laufs4; Janne Petersen1; Kristoffer Jarlov Jensen1
MATERIALS AVAILABLE
prevalence-of-cvi-in-denmark-poster-aha26-final-29-oct-26-hr-for-submission-1
Poster
15:50  - 15:55
CST
MDP1839
POSTER
Integrating High-Sensitivity C-Reactive Protein Into Risk Equations for Individuals With Established Atherosclerotic Cardiovascular Disease
Chi Nguyen1; Jeffrey R. Skaar1; Guanghao Zhang1; Chioma Uzoigwe1; Kerem Ozer1; Alexander T.S. Sandhu2,3
MATERIALS AVAILABLE
aha-2026-spiro-eposter
Slide
Monday, 09 November 2026
09:50  - 09:55
CST
MDP2055
POSTER
Inflammatory risk and cardio-renal outcomes in adults with chronic kidney disease: a nationwide study
Katherine Tuttle1; Faizan Mazhar2; Minjung Han2; Brendon L Neuen3; Aurora Caldinelli2; Magnus Fugger4; Sofia Gerward4; Jimmi Mathisen4; Marie Evans5; Juan J Carrero2
MATERIALS AVAILABLE
nncv180b-tuttle-16x9-l-v9-amb-final-30-oct-2026-for-upload-1
Poster
10:04  - 10:09
CST
MDP2057
POSTER
Global study of cardiovascular inflammation and 10-year cardiovascular risk in patients with atherosclerotic cardiovascular disease with and without chronic kidney disease: analysis from the POSEIDON study  
Kausik K Ray1; Deepak L Bhatt2; Zaklina Davicevic-Elez3; Sofia Gerward3; Nicole M Isbel4; Jimmi Mathisen3;  Shelley Zieroth5; Frank LJ Visseren6
MATERIALS AVAILABLE
ray-et-al-poseidon-smart2-risk-score-poster-aha26-final-28-oct-26-hr-for-submission-1
Poster
Keywords
Cardiovascular Disease
AHA